Moxifloxacin vs. Polytrim for Conjunctivitis
Completed · Phase 4
Conditions studied: Conjunctivitis
In brief
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Key facts
- Study ID
- NCT00581542
- Run by
- University of Rochester
- People needed
- 124
- Starts
- 2007-03-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2016-01-18
Who can join
Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 1 - 18 years of age with presumed bacterial conjunctivitis.
You may not qualify if…
- Previous antibiotics or to receive systemic antibiotic.
Where it is running
- University of Rochester — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.